http://www.eubusiness.com Latest news on the pharmaceutical policies of the European Union.<hr /> <p>Advertisement</p> <div><script type="text/javascript"><!-- google_ad_client = "ca-pub-3125363935929935"; /* MPU */ google_ad_slot = "4186015603"; google_ad_width = 300; google_ad_height = 250; //--> </script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script></div><hr /> daily 1 2007-01-02T13:22:44Z http://www.eubusiness.com/topics/social/drug-markets-13 Europe is entering an important new era in the supply and demand for illicit drugs -- a development which is challenging current policies and responses. This is according to the first joint EU drug markets report from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol released today in Brussels. The two EU agencies have joined forces to provide the first strategic analysis of the European illicit drug market in its entirety. In the report, they describe a market which is increasingly dynamic, innovative and quick to react to challenges and one which requires an equally dynamic, innovative and agile response across Europe. The report unveils the ‘changing face of organised crime in Europe’: while, historically, the EU drug market has focused on specific drugs trafficked by specialised operators along well-defined routes, the contemporary market is more ‘fluid’, with new routes and multi-substance consignments becoming more common. No publisher eub2 drugs Social Health Crime 2013-01-31T16:56:01Z Guide http://www.eubusiness.com/news-eu/concurrence-pharma.m3k European anti-trust authorities said Thursday they had sent written objections to pharmaceutical giants Johnson & Johnson and Novartis over a deal affecting generic medicine. No publisher eub2 Text and Picture Copyright 2013 AFP. All other Copyright 2013 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. pharmaceutical pharma concurrence competition Headline2 2013-01-31T15:27:32Z News Item http://www.eubusiness.com/news-eu/macedonia-drugs.lnk Macedonian police have seized some 350 kilogrammes (771 pounds) of marijuana bound for the European Union, worth up to one million euros ($1.3 million), and arrested 15 people, a minister said on Tuesday. No publisher eub2 Text and Picture Copyright 2013 AFP. All other Copyright 2013 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. drugs Macedonia 2013-01-08T21:02:49Z News Item http://www.eubusiness.com/news-eu/germany-pharma.l6p German drug maker Bayer said on Wednesday that European Union authorities had given the go-ahead for a new contraceptive which can prevent pregnancies for up to three years. No publisher eub2 Text and Picture Copyright 2012 AFP. All other Copyright 2012 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. product pharma company health Germany Bayer Headline2 2012-12-05T10:27:28Z News Item http://www.eubusiness.com/news-eu/crime-drugs.krr Europe is being bombarded with an array of new, synthetic drugs of which the ingredients and effects on users are unknown, the continent's drug agency warned in a report on Thursday. No publisher eub2 Text and Picture Copyright 2012 AFP. All other Copyright 2012 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. drugs Headline2 crime 2012-11-15T13:04:53Z News Item http://www.eubusiness.com/topics/pharma/biopiracy Researchers and companies in the EU received a boost today with a new proposal that should provide reliable access to genetic resources from outside the Union. The proposal – a draft Regulation that would implement the 'Nagoya Protocol on Access to Genetic Resources and Benefit-sharing' – is designed to protect the rights of countries and of indigenous and local communities that allow their genetic resources and associated traditional knowledge to be used, while also giving researchers in Europe improved, reliable access to quality samples of genetic resources at low cost with high legal certainty. No publisher eub2 Pharmaceuticals Research & Technology 2012-10-04T17:59:04Z Guide http://www.eubusiness.com/news-eu/environment-pharma.ini The European Union on Thursday set out proposals aimed at thwarting the illegal use of genetic resources and traditional medicine, a practice known as bio-piracy. No publisher eub2 Text and Picture Copyright 2012 AFP. All other Copyright 2012 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. biotech biodiversity pharma environment Headline1 2012-10-04T17:52:10Z News Item http://www.eubusiness.com/news-eu/canada-pharma-trade.ifg A proposal to extend drug patents in Canada as part of a free trade pact being negotiated with the European Union provoked a backlash this week over fears it would push up health care costs. No publisher eub2 Text and Picture Copyright 2012 AFP. All other Copyright 2012 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. Canada pharma trade 2012-09-19T21:49:51Z News Item http://www.eubusiness.com/news-eu/industry-pharma.hvs The European Commission has extended an anti-trust probe into French pharmaceutical maker Les Laboratoires Servier to include the Danish laboratory Lundbeck. No publisher eub2 Text and Picture Copyright 2012 AFP. All other Copyright 2012 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. probe pharma industry Servier competition Headline2 company 2012-07-25T22:34:09Z News Item http://www.eubusiness.com/news-eu/social-drugs.hfi The market share of cannabis herb is steadily increasing across Europe at the expense of imported cannabis resin, says the European Monitoring Centre for Drugs and Drug Addiction. No publisher eub2 Text and Picture Copyright 2012 AFP. All other Copyright 2012 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable. drugs cannabis Headline2 social 2012-06-26T13:55:20Z News Item http://www.eubusiness.com/topics/health/antimicrobial-resistance With about 25,000 patients dying per year in the EU from infections caused by drug resistant bacteria and related costs of over 1.5 billion euros in healthcare expenses and productivity losses , antimicrobial resistance is a growing health problem in the EU. Today, on the eve of European Antibiotic Awareness Day, the European Commission tabled a comprehensive Action Plan on Antimicrobial resistance (AMR) which unveils12 concrete actions to be implemented in close cooperation with the EU Member States. No publisher eub2 Research & Technology Pharmaceuticals Health 2011-11-17T16:57:06Z Guide http://www.eubusiness.com/topics/pharma/prescription-medicines-2 The European Commission has adopted revised proposals clarifying the information that industry can supply to the public on prescription-only medicines. No publisher eub2 medicine Pharmaceuticals 2011-10-11T20:15:36Z Guide http://www.eubusiness.com/topics/pharma/clinical-trials From 22 March 2011, all EU citizens have access to information on the thousands of authorised pharmaceutical clinical trials that are under way in the EU. The aim of this official public register is to make clinical research on pharmaceuticals more transparent for patients and others and to avoid unnecessary duplication of clinical trials. Every year approximately 4000 clinical trials are authorised in the EU. Since most of them last 2 to 3 years, this means that around 10,000 trials are ongoing at any given time. No publisher eub2 Pharmaceuticals Health 2011-03-22T16:57:00Z Link http://www.eubusiness.com/topics/health/emea The European Medicines Agency is a decentralised body of the European Union, located in London. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. No publisher eub2 Pharmaceuticals Health 2010-09-23T20:06:07Z Link http://www.eubusiness.com/news-eu/mergers-merck.807 The European Commission has cleared under the EU Merger Regulation the acquisition of Millipore, a US-based life science group of companies by the German pharmaceutical and chemical company Merck. No publisher inadim Pharmaceuticals EU Law - competition mergers 2010-07-08T14:39:50Z News Item